| |||||||||
ISMP Canada NewsMarch 15, 2019: Health Canada: Increased risk of blood clots and of death in rheumatoid arthritis patients on high dose of tofacitinib (Xeljanz) |
|||||||||
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved. |